TORONTO, March 8, 2018 /PRNewswire/ – Baylis Medical Company is proud to announce that it has been named a 2018 winner of Canada’s Best Managed Companies, one of the country’s leading business award programs honouring excellence in Canadian-owned and managed businesses. Established in 1993, Canada’s Best Managed Companies recognizes those that demonstrate […]
Financial
CryoLife Reports Fourth Quarter and Full Year 2017 Results
ATLANTA, March 7, 2018 /PRNewswire/ — Fourth Quarter and Recent Business Highlights: Achieved fourth quarter revenues of $52.8 million Achieved double digit revenue growth on a percentage basis in BioGlue®, On-X, and tissue processing Recorded GAAP net loss of ($3.0) million, or ($0.09) per fully diluted common share; Non-GAAP net income of $4.0 million, or $0.11 per fully diluted […]
Cardiac Resynchronization Therapy Systems Market Expected to Reach USD 4.9 Bn Globally in 2025; Says TMR
ALBANY, New York, March 8, 2018 /PRNewswire/ — The global Cardiac Resynchronization Therapy Systems market was valued at approximately US$ 3.1 Bn in 2016 is projected to register cumulative annual growth rate (CAGR) of over 5.3% from 2017 to 2025, according to a new report published by Transparency Market Research (TMR) titled “Cardiac Resynchronization […]
LivaNova Enters into Definitive Agreement to Divest Its Cardiac Rhythm Management Business Franchise to MicroPort Scientific Corporation
LONDON–(BUSINESS WIRE)– LivaNova PLC (NASDAQ:LIVN) (“LivaNova”) today announced that it has entered into a definitive Stock and Asset Purchase Agreement (“Purchase Agreement”) to divest its Cardiac Rhythm Management business franchise to MicroPort Scientific Corporation (“MicroPort”). LivaNova and MicroPort executed and delivered the Purchase Agreement, pursuant to the terms of a binding Letter of Intent, […]
Avinger Regains Compliance with Nasdaq Listing Requirements
REDWOOD CITY, Calif., March 02, 2018 (GLOBE NEWSWIRE) — Avinger, Inc. (Nasdaq:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced it has regained compliance with Nasdaq listing requirements. In a letter dated March 1, 2018, Nasdaq informed the Company that it has achieved compliance with […]
Jason Field to Succeed Terri Kelly as President and CEO of W. L. Gore & Associates
NEWARK, Del.–(BUSINESS WIRE)–W. L. Gore & Associates today announced that Jason Field, global sales and marketing leader for Gore Medical Products Division, will succeed Terri Kelly in the role of President and CEO effective April 1, 2018. Terri Kelly will continue to serve on Gore’s Board of Directors through July 2018. […]
Global Embolic Protection Devices Market 2018-2023 by Type, Material, Application, Indication – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Embolic Protection Devices Market by Type (Distal Filter, Distal Occlusion, Proximal Occlusion), Material (Nitinol, Polyurethane), Application (Cardiovascular, Neurovascular, Peripheral), Indication (PCI, SVD, TAVR) – Global Forecast to 2023” report has been added to ResearchAndMarkets.com’s offering. The Global Embolic Protection Devices Market is Projected to Reach USD 604.9 Million By 2023 from USD […]
Tricuspid Valve Repair Company 4Tech Inc. Appoints Tom Fleming as President and CEO, and Dr. Keith Dawkins as CMO
GALWAY, Ireland–(BUSINESS WIRE)– 4Tech Inc., a leader in the field of transcatheter tricuspid valve repair, announces changes in its leadership team: Tom Fleming will join the company as President and Chief Executive Officer (CEO), effective as of March 2018; and Keith D. Dawkins, M.D., has joined as Chief Medical Officer (CMO), effective immediately. Tom […]
Cardiva Medical Brings Total Financing Round to $41 Million; Announces Sponsorship of AMBULATE Trial, First Vascular Closure Trial Targeted at High Growth Electrophysiology Procedures
New Vascular Closure Device for Multi-Access Mid-Bore Vein Procedures, Specifically Cardiac Ablation, Aims to Reduce Time to Ambulation and Improve the Patient Experience SANTA CLARA, Calif.–(BUSINESS WIRE)– Cardiva Medical ®, an innovator in the field of vascular closure, today announced that the company has closed on $11 million in additional financing – […]
Mitralign raises $10m
Mitralign raises $10m FEBRUARY 21, 2018 BY BRAD PERRIELLO, MassDevice Mitralign, which is looking to commercialize its namesake mitral valve treatment and pursue regulatory nods for its Trialign tricuspid valve device, said it raised nearly $10 million. The $9.8 million funding, of a hoped-for $30.2 million, came from 19 unnamed investors beginning […]